Lipid M structure
|
Common Name | Lipid M | ||
|---|---|---|---|---|
| CAS Number | 2089251-57-8 | Molecular Weight | 710.17 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C44H87NO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Lipid MLipid M (pKa: 6.75) can be used to deliver mRNA vaccine and yield a robust immune response with improved tolerability[1]. |
| Name | Lipid M |
|---|
| Description | Lipid M (pKa: 6.75) can be used to deliver mRNA vaccine and yield a robust immune response with improved tolerability[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Lipid M (50 μL containing 2 μg of luciferase mRNA formulated in LNPs, i.m.) is followed by rapid clearance in muscle, spleen and liver in CD-1 mice[1]. Lipid M (300 μL containing 500 μg IgG mRNA formulated in LNPs, i.m.) yields serum antibody expression comparable to that of MC3-based LNPs in cynomolgus monkeys[1]. |
| Molecular Formula | C44H87NO5 |
|---|---|
| Molecular Weight | 710.17 |